. Its integrity is highly dependent on resident self-renewing stem cells located in the basal layer of the stratified epidermis. Stem cells have to balance selfrenewal and differentiation to maintain proper tissue homeostasis and respond to a variety of conditions, including tissue injury. This proper balance is achieved in part by a milieu of micro-environmental signals controlling stem cell fate decisions and their cellular responses.
G-protein-coupled receptors (GPCRs) are the largest family of cell-surface molecules involved in signal transduction, and play central roles in numerous physiological processes and pathological conditions 6, 7 . However, our understanding of the functions of GPCRs and their linked heterotrimeric G proteins in stem cell biology in vivo is still largely incomplete. Here, by focusing on the role of Gα s on stem cell fate using the epidermis as a model system, we demonstrate that this Gα-protein exerts a central role in coordinating self-renewal and differentiation in epithelial stem cells. Alone, conditional epidermal deletion of Gnas or inactivation of protein kinase A (PKA) in mice was sufficient to cause an aberrant expansion of the stem cell compartment, resulting in the rapid formation of basal-cell carcinoma (BCC)-like lesions. In contrast, expression of active Gα s caused hair follicle stem cell exhaustion and hair loss. Mechanistically, Gα s and PKA disruption promoted the concomitant cell autonomous activation of GLI and YAP1. These findings support a central role for Gα s and PKA in stem cell fate decisions in mammals, and reveal a tumour suppressive mechanism by which the Gα s -PKA signalling axis limits the aberrant proliferation of epithelial stem cells and maintains hair follicle and skin homeostasis.
RESULTS

Gnas deletion in the skin is sufficient to induce BCC-like lesions
To explore the role of Gα s in stem cell fate we generated epidermalspecific Gnas knockout mice. Mice expressing a tamoxifen-inducible Cre driven by the keratin 14 promoter (K14CreER), which targets the epidermal stem cell compartment 8 , were crossed with mice carrying loxP sites surrounding Gnas exon one 9 ( Fig. 1a) . Unexpectedly, all Gnas epidermal knockout mice (Gnas eKO) developed skin lesions characterized by thickening of the epidermis and hair loss, primarily on the ears, snout and paws, only a few weeks after Gnas excision (Fig. 1b,c and Supplementary Fig. 1 ). Histologically, these lesions exhibited extensive proliferation of basaloid cells, which formed clumps and islands that deeply invaded the underlying stroma (Fig. 1d ). Tumours were morphologically similar to superficial and Gnas eKO skin shows basaloid cells growing in the stroma resembling micronodular and superficial BCC. (e) Example of human normal and BCC skin histopathology. (f-j) Representative pictures of the skin of WT and Gnas eKO animals stained to show expression of the stem cell marker p63 (green) and the basal progenitor marker cytokeratin 5 (CK5, red) (f); the proliferation marker Ki67 (green) and nuclei (blue) (g); CK5 (red), α 6 integrin (green) and nuclei (blue) (h); the hair follicle marker cytokeratin 15 (CK15, red) and nuclei (blue) (i); and the differentiation marker loricrin (red) and nuclei (blue) (j). Inset panels in each images show details at higher magnification. The location of the basal membrane is indicated with a white dotted line.
nodular human BCCs (ref. 10 ; Fig. 1e ), developing in body regions aligned with previous BCC mouse models 11, 12 . The epidermal basal identity of tumour lesions in Gnas eKO mice was confirmed by the expression of the basal marker cytokeratin 5 (CK5) and the stem cell marker p63 (Fig. 1f) . Cells showed altered proliferation patterns and polarity, as reflected by Ki67 (Fig. 1g ) and integrin α 6 staining, respectively (Fig. 1h) , and were positive for the hair follicle and BCC marker cytokeratin 15 (CK15; ref. 13 ; Fig. 1i ) but negative for the differentiation marker loricrin (Fig. 1j) . Increased thickness of the CK15+ skin layer ( Supplementary Fig. 1c ) and multiple additional markers reflected the expansion of the basal cells. Thus, deletion of Gnas from mouse epidermis is sufficient to induce rapid expansion of the stem cell compartment and development of lesions resembling BCC.
Transcriptional analysis in Gnas eKO mice uncovers the activation of Hedgehog GLI and Hippo YAP1 transcriptional networks Gene ontology analysis of transcripts in the skin of Gnas eKO mice showed significantly increased expression of genes associated with epithelial development (Fig. 2a) . Analysis of upregulated transcriptional signatures revealed alterations in multiple transcriptional networks (Supplementary Table 1 ) that were filtered by focusing on transcription factors with known functions in hair follicle and epidermal stem cell maintenance. These included GLI1, NFAT family genes, TP63, EZH2 and YAP1 (Fig. 2b) . Interestingly, GLI transcription factors are the main drivers of human BCC development 3, 10, 11, 14 . We confirmed the overactivation of the GLI transcriptional network by analysing the messenger RNA levels of Hedgehog-signalling members in Gnas eKO mice (Fig. 2c,d ). Although GLI members and their transcriptional targets Ptch1 and Ptch2 were all upregulated, we did not detect increased mRNA levels of Sonic Hedgehog (Shh) or Indian Hedgehog (Ihh; Fig. 2c ). This might indicate that the stimulation of GLI signalling in Gnas eKO mice is cell autonomous, and does not depend on the increased expression of these PATCH ligands.
Lesions in Gnas eKO mice seemed to originate from hair follicles, raising the possibility that BCC development might be due to an amplification of a subset of hair follicle stem cells. Indeed, several transcriptional regulators of hair follicle stem cell maintenance and proliferation 12 were upregulated in Gnas eKO mice (Fig. 2e) . Interestingly, GLI transcription factors are essential for hair follicle stem cell regeneration 3, 15 and the Hedgehog response gene Gli1 defines (k,l) Immunostaining (k) and quantification (l) of YAP1 expression in human normal skin and BCC. n = 3 normal and 6 BCC tissue sections. Data are presented as means ± s.e.m., and significance was calculated by ANOVA and Student's t-test (NS P > 0.05; * P < 0.05; * * P < 0.01; and * * * P < 0.001).
a subset of stem cells that can regenerate the hair follicle and migrate into skin wounds during healing 16 . To track GLI1 + cells after Gnas deletion we took advantage of GLI reporter mice (Gli lz ; ref. 17). As previously described 2, 16 , in Gnas wild-type (WT) Gli lz mice, GLI1 is expressed almost exclusively in the isthmus and secondary hair germ of resting hair follicles (Fig. 2f,g ). After Gnas deletion, however, GLI1 + cells expanded to the entire hair follicle and spread to the interfollicular epidermis (Fig. 2g) . In advanced lesions, most of the epidermis was replaced by GLI1 + cells (Fig. 2g) . These results confirmed the overactivation of the Hedgehog GLI signalling network following Gnas deletion and suggested that BCC-like lesions might arise from an expansion of GLI + hair follicle stem cells. In the search for additional mechanisms leading to the massive hair follicle stem cell expansion after Gnas deletion, we next focused on YAP1, a transcriptional co-activator that maintains the self-renewal capacity and undifferentiated state of epidermal skin progenitor cells 18 . Recent reports indicate that YAP1 activity is tightly regulated by GPCRs (ref. 19 ). Indeed, YAP1 transcriptional activity was significantly increased in Gnas eKO mice (Fig. 2b) , concomitant with increased YAP1 nuclear localization (Fig. 2h,i) . Furthermore, a YAP1 transcriptional signature differentiated mRNAs from Gnas eKO mice from control mice by unsupervised hierarchical clustering (Fig. 2j) . This approach helped identify multiple YAP1 targets that were significantly upregulated in Gnas eKO skin (Supplementary Table 2 ). Human BCCs also show a significant increase in nuclear YAP1 throughout the tumour lesion (Fig. 2k,l) . Together, these results suggest that YAP1 activity in the epidermis might be tightly regulated by Gα s , and that YAP1 deregulation may contribute to BCC formation in mice and humans.
Gnas eKO triggers ectopic activation of GLI and YAP1
To further explore the role of GLI and YAP1 in stem cell expansion, we focused on early events triggered by Gnas deletion, before any phenotypic alterations were detected. Using whole mount of tail epidermis, we observed that shortly after Gnas excision (one day following tamoxifen treatment) GLI is ectopically activated in the base of the isthmus of Inset panels in images show details at higher magnification. Hair follicles are delineated with a white dotted line. Data are presented as means ± s.e.m., and significance was calculated by ANOVA and Student's t-test ( * * P < 0.01; and * * * P < 0.001).
hair follicles (Fig. 3a,b) , and whole-mount-immunofluorescence analysis revealed high nuclear localization of YAP1 in multiple areas within the base of hair follicles and interfollicular epidermis (Fig. 3c,d and Supplementary Fig. 2a ). We confirmed the rapid increase in nuclear localization of YAP1 in ear skin sections ( Supplementary Fig. 2b ). These results provide evidence that increased YAP1 and GLI signalling precedes stem cell expansion and raise the possibility that YAP1 and GLI probably represent the drivers of BCC formation.
We next investigated the impact of Gnas deletion in epidermal cells by studying the repopulating capacity of individual epidermal stem cells in vitro 20, 21 . Cells isolated from the epidermis of Gnas eKO mice showed remarkably increased colony formation efficiency (Fig. 3e) , confirming the expansion of the stem cell population. Furthermore, keratinocytes derived from Gnas eKO Gli lz reporter mice showed increased LacZ+ colonies compared with WT cells and even WT cells treated with the Hedgehog-signalling activator SAG (ref. 22 ; Fig. 3f ). To confirm the importance of GLI and YAP1 for the expansion of Gα s -depleted cells we performed RNA-interference experiments. Reduced expression of YAP1 or GLI1 resulted in a significant decrease in the colony-forming efficiency of Gnas eKO cells (Fig. 3g) . The broader impact of YAP1 knockdown might reflect the more extensive activation of YAP1 compared with GLI1 in Gnas eKO mice, or that other GLI transcription factors are involved in the proliferation of BCC cells. These results suggest that Gnas eKO triggers an ectopic and cell autonomous increase in GLI and YAP1 activity, which may contribute to aberrant epidermal stem cell proliferation.
Gα s restrains Hedgehog and YAP signalling through PKA
The absence of Gα s in the epidermis resulted in increased GLI and YAP1 signalling, suggesting that under normal conditions Gα s might limit the transcriptional activity of these stem cell regulators. Gα s controls a myriad of signalling networks, including cyclic AMP signalling, cellular metabolism and intracellular trafficking 23, 24 . In the search for potential mechanisms underlying the impact of Gnas deletion we focused on the protein kinase A (PKA), one of the main signalling effectors of Gα s downstream of cAMP activation 25 . To limit PKA activity, we took advantage of the PKA inhibitor protein (PKI; ref. 26 ) and fused its PKA-interacting residues downstream of GLI1 activity was measured by GAL4GLI1/UASLuc and YAP1 by GAL4TEAD/UASLuc reporters. The constitutive active mutant Gα s R201C was used to mimic Gα s activation and PKI was used to block PKA activity (see also Supplementary Fig. 3 ). n = 3 independent experiments. (e) Phosphorylation of GLI1 by PKA. 293 cells were transfected with the indicated DNAs and GLI1HA. Then, cells were treated with forskolin (FSK) for 30 min and GLI1HA was immunoprecipitated and tested with two different anti-phospho-PKA substrate motif antibodies that detect proteins containing phospho-serine/threonine residues with arginine at the −3 and −2 positions (RXX(S * /T * ) and RRX(S * /T * )). Full images of blots are shown in Supplementary Fig. 6 . (f) Transcriptional activity of GLI1 in NIH3T3 cells measured by GAL4GLI1/UASLuc reporters co-transfected with the indicated DNAs and treated or not with cyclopamine. n = 3 independent experiments. (g,h) Quantification (g) and representative pictures (h) of βGal staining of keratinocytes from WT Gli lz and Gnas eKO Gli lz mice treated with the indicated drugs for 48 h. Cells isolated from WT or Gnas eKO mice were plated in triplicate, treated and positive and negative cells were counted (between 1,000 and 1,500 cells per condition were counted). One representative experiment of three is shown. RLU: relative luciferase units; Cy: cyclopamine; FI: forskolin + IBMX. Data are presented as means ± s.e.m., and significance was calculated by ANOVA and Student's t-test (NS P > 0.05; * P < 0.05; * * P < 0.01; and * * * P < 0.001).
GFP (GFP-PKI; Fig. 4a ). Critical PKI residues were also mutated to disrupt binding to PKA (GFP-PKI4A) and used as a control (Fig. 4a) . We also used a constitutively active mutant form of Gα s (Gα s R201C; ref. 6) or increased the intracellular levels of cAMP by combining forskolin and 3-isobutyl-1-methylxanthine (IBMX), to confirm that GFP-PKI but not GFP-PKI4A blocks PKA signalling ( Fig. 4b and Supplementary Fig. 2a,b) .
These experimental tools demonstrated that the activation of PKA by Gα s exerts a remarkable negative impact on the transcriptional activity of GLI1 and YAP1 (Fig. 4c,d ), the latter in line with recent reports 27, 28 . Furthermore, PKA could phosphorylate GLI1 (Fig. 4e) . This phosphorylation is known to regulate GLI transcriptional activity 29 , suggesting that Gα s may control GLI directly through PKA, independently of Hedgehog signalling. Indeed, PKA inhibition by GFP-PKI was alone sufficient to significantly increase GLI1 transcriptional activity in 293 (Fig. 4c ) and NIH3T3 cells (Fig. 4f ). This effect seems to be independent from the Hedgehog-signalling protein smoothened (SMO), because GLI1 activation by GFP-PKI was only partially reduced by the SMO inhibitor cyclopamine (Fig. 4f) .
To further explore this possibility we used keratinocytes derived from WT or Gnas eKO mice expressing the Gli lz reporter. GLI transcriptional activity induced by SAG was abolished in Gnas WT Gli lz keratinocytes by cyclopamine treatment (Fig. 4g,h ). Instead, in Gnas eKO Gli lz keratinocytes, GLI activity was only partially diminished by cyclopamine (Fig. 4g,h) , and increasing the intracellular levels of cAMP had a stronger effect (Fig. 4g,h and , and significance was calculated in the nucleus fraction by Student's t-test against the control of the same group (NS P > 0.05; * * P < 0.01; and * * * P < 0.001). Full images of blots are shown in Supplementary Fig. 6 . Supplementary Fig. 4 ). Moreover, increased cAMP levels (but not cyclopamine) repressed the transcriptional activity of YAP1 in Gnas eKO keratinocytes, as judged by the levels of its transcriptional target Ctgf ( Supplementary Fig. 4 ). Interestingly, deletion of Gnas also sensitized cells to Hedgehog pathway activation by SAG (Fig. 4g,h ), supporting that Gnas acts to restrain Hedgehog signalling.
PKA mediates Gα s inactivation of YAP1 through LATS
YAP1 activity is mostly regulated post-transcriptionally through the inhibitory components of the Hippo pathway, which converge on the activation of LATS kinases that phosphorylate YAP1, inducing its cytoplasmic retention 30, 31 . Using a human keratinocyte cell line (HACAT) in which YAP1 is active under non-confluent conditions, stimulation of cAMP led to an increase in YAP1 phosphorylation and LATS1 activation, the latter revealed by its phosphorylation at the activation loop (Ser 909; Fig. 5a ). The induction of cAMP resulted in the phosphorylation of LKB1 and the Hippo core components MST1/2 (Fig. 5a) , both of which have been shown to activate LATS and inhibit YAP1 (refs 30-32) . cAMP elevation also resulted in cytoplasmic retention of YAP1 in non-confluent cell cultures (Fig. 5b) .
To investigate how PKA represses YAP1 activity, we used the cytoplasmic retention induced by cAMP as readout in RNAinterference experiments. Among the Hippo pathway components, only knockdown of LATS1/2 rescued the inhibitory effect of increased cAMP (Fig. 5c) , suggesting that LATS kinases mediate PKAinduced YAP1 inhibition, at least in part independently of the core Hippo pathway components MST1/2 and SAV. Interestingly, LKB1 knockdown did not protect YAP1 from cAMP-mediated inhibition, but knockdown of the NF2 tumour suppressor partially rescued this effect (Fig. 5c ). NF2 organizes Hippo signalling at the plasma membrane and coordinates the activation of LATS kinases and YAP1 phosphorylation 33 . Indeed, knockdown of LATS1/2 and NF2 abolished the cAMP-induced phosphorylation of YAP1, whereas knockdown of MST1/2, SAV and LKB1 had no effect (Fig. 5d) . NF2 knockdown also blocked the increased LATS1 phosphorylation induced by cAMP (Fig. 5d) , supporting that NF2 contributes to the PKA-induced activation of LATS.
Inhibition of PKA in the skin is sufficient to phenocopy Gnas eKO As PKA mediates the inhibitory effects of Gα s on GLI and YAP1, we next challenged the possibility that reduction in PKA activity might initiate BCC development. We generated mice expressing GFP-PKI and GFP-PKI4A under the control of the Tet-responsive element and bred them with mice expressing the reverse tetracyclineactivated transactivator rtTA2 under the control of the cytokeratin 5 promoter (K5rtTA), targeting the epidermis and its stem cell compartment 34, 35 (Fig. 6a) . ) qRT-PCR analysis of mRNA levels of Yap1 and the YAP1-regulated gene Ctgf, and transcriptional regulators and markers essential for hair follicle stem cell maintenance and proliferation in primary cultures of keratinocytes from K5rtTA Tet-GFP-PKI mice compared with cultures from WT littermates. n = 3 independent cultures from 3 WT and 3 K5rtTA Tet-GFP-PKI mice. Data are presented as means ± s.e.m., and significance was calculated by ANOVA and Student's t-test (NS P > 0.05; * * P < 0.01; and * * * P < 0.001). Inset panels in images show details at higher magnification. The location of the basal membrane is indicated with a white dotted line.
When GFP-PKI (but not GFP-PKI4A) was expressed in the epithelium in response to doxycycline, mice rapidly developed extensive lesions in the skin, revealing histological features similar to human BCC that were indistinguishable from those of Gnas eKO mice (Fig. 6b,c) . Skin and basal epithelial growths were positive for GFP (Fig. 6c) , indicating the expression of GFP-PKI and GFP-PKI4A. Staining for CK5 and p63 confirmed the basal epithelial identity of these cells (Fig. 6d ). Lesions were also positive for the hair follicle and BCC marker CK15 and showed altered proliferation patterns by Ki67 staining (Fig. 6e,f) . Using Gli lz reporter mice, we observed an expansion of GLI+ cells after GFP-PKI expression (Fig. 6g ). Lesions were also positive for nuclear YAP1 (Fig. 6h) . Furthermore, YAP1 was activated in K5rtTA Tet-GFP-PKI keratinocytes, as measured by increased levels of the YAP1 transcriptional targets Ctgf and Cyr61, as well as transcriptional regulators of hair follicle stem cell maintenance and proliferation (Fig. 6i) .
Overactivation of Gα s induces epithelial stem cell differentiation and depletion
To investigate the impact of activating Gα s in the stem cell compartment, we next developed doxycycline-inducible mice expressing Gα s R201C (Tet-Gα s R201C) and bred them with K5rtTA mice (Fig. 7a) . Gα s R201C expression was rapidly induced in keratinocytes derived from K5rtTA/Tet-Gα s R201C mice after doxycycline treatment (Fig. 7b) . Remarkably, the persistent expression of active Gα s in mouse epidermis resulted in progressive hair loss (Fig. 7c) in both males and females. Hair follicles in K5rtTA/Tet-Gα − sR201C mice terminally differentiated into keratinized cyst structures (Fig. 7d) , suggesting that Gα s activation in the skin induces the nearly complete differentiation and exhaustion of hair follicle stem cells. Supporting this hypothesis, CD34+ hair follicle stem cells were depleted in K5rtTA/Tet-Gα s R201C mice (Fig. 7e) . Gα s activation also led to a reduction in the basal progenitor markers p63 and CK5 (Fig. 7f) and decreased cell proliferation (Ki67 staining, Fig. 7g) , particularly in the hair follicles. Furthermore, expression of Gα s R201C resulted in a significant reduction in the colony-forming efficiency of epidermal cells ( Supplementary Fig. 5a,b) . By using whole-mount tail epidermis, we observed that Gα s R201C induced the cytoplasmic retention of YAP1 and a decrease in the hair follicle stem cell marker CK15 (Fig. 7h and Supplementary Fig. 5c ). Finally, cultured keratinocytes from K5rtTA/Tet-Gα s R201C mice showed increased expression of differentiation markers (Fig. 7i) , and a concomitant reduction in hair follicle stem cell markers and GLI and YAP1 transcriptional activity (Fig. 7j) . Collectively, these results support the emerging concept that Gα s acts as a key regulator of epithelial stem cell fate in the skin.
Strikingly, the cyst formation observed on K5rtTA/Tet-Gα s R201C mice resembles the skin phenotype of mice in which β-catenin is lost or repressed 36, 37 . However, by measuring the levels of Axin2 mRNA, a well-known marker of β-catenin function, we could not find any differences in β-catenin pathway activation (not shown). One possible connection is that in β-catenin KO skin SHH signalling is lost 36 . Similarly, increased Gα s signalling blocks the transcriptional activity of GLI, suggesting that in both cases, suppression of Hedgehog signalling might result in hair follicle progenitor cells losing their follicular differentiation and instead exhibiting squamous epidermal characteristics, forming hair follicle-derived cysts 36 . Indeed, formation of epidermal-like cyst structures has been observed by conditional disruption of SHH signalling in the skin 38 .
DISCUSSION
We demonstrate here that Gα s and PKA signalling function as non-canonical regulators of GLI and YAP1 transcriptional networks, controlling the proliferation and differentiation of epithelial stem cells and maintaining proper hair follicle and skin homeostasis (Fig. 8a) .
PKA signalling can limit the activity of the Hedgehog pathway by an incompletely understood mechanism [39] [40] [41] [42] . Here we show that Gα s controls GLI activity directly through PKA, independently of SHH or SMO, and that repression of Gα s or PKA alone is sufficient to induce a cell autonomous increase on GLI-dependent transcription. We also present evidence that repression of Gα s or PKA results in the parallel activation of the YAP1 transcriptional network. Recent evidence indicates that PKA can block YAP1 through the activation of LATS kinases 27, 28 . Our experiments extend these previous findings, establishing that PKA mediates the inactivation of YAP1 downstream of Gα s through LATS by a mechanism that involves the NF2 tumour suppressor protein. In this regard, NF2 can be directly phosphorylated by PKA and this phosphorylation renders NF2 in an open conformation [43] [44] [45] , known to be required for its interaction with LATS (ref. 33) .
SHH and SMO signalling can increase YAP1 activity by upregulating its mRNA levels 46, 47 . However, we did not observe any increase in Yap1 or Shh mRNAs on Gα s or PKA inactivation, and inhibition of SMO signalling by cyclopamine did not have any effect on the transcriptional activity of YAP1. On the other hand, YAP1 can induce expression of GLI1 mRNA (ref. 46 ), but YAP1 activation might not be sufficient to trigger Hedgehog signalling. Indeed, skin-specific knockout of Hippo signalling components resulting in increased YAP1 activity 33, [48] [49] [50] or overexpression of active mutants of YAP1 (refs 18,51) does not result in the development of BCC-like lesions. Moreover, activation of GLI and YAP1 signalling occurs in both overlapping and distinct anatomical locations after Gnas deletion. Thus, although an interplay between YAP1 and GLI may occur, the available information points towards the concomitant parallel activation of YAP1 and GLI, both initiated downstream from PKA inhibition (see Fig. 8 ). Of interest, although the evidence presented indicates that this activation of GLI and YAP1 might be the main cause of BCC development in our mouse models, several additional transcriptional networks were also upregulated after Gnas excision (Supplementary Table 1 ). The elucidation of their precise intervening molecular mechanisms and potential cooperating roles in BCC development warrants further investigation.
Deregulation of the expression and activity of heterotrimeric G proteins and GPCRs is frequently observed with human malignancies 6 . Activating mutations in GNAS promote aberrant growth of human thyroid 52 and pituitary tumours 53 and are found in multiple other neoplasms 6 . In contrast to its well-established tumour promoting role, our findings suggest that Gα s and its downstream effector PKA function as part of a tumour suppressive pathway in the skin. The disruption of this signalling axis is sufficient to promote rapid stem cell expansion and BCC formation, at least in part by relieving the restraining effect of Gα s and PKA on YAP1 and GLI (Fig. 8) . These findings raise the possibility that Gα s and PKA might function as tumour suppressor genes in hyperproliferative diseases driven by GLI and YAP1 activation. In line with this, inactivating genomic alterations in GNAS have been found in SHH-driven medulloblastoma 42, 54 , and ablation of Gnas in neural progenitors promotes medulloblastoma formation in mice with increased SHH signalling 42 , suggesting that the tumour suppressive function of Gα s -PKA may have broad implications in multiple pathophysiological conditions. Finally, GPCRs are essential for the maintenance of the epidermal stem cell compartment 3, 5 . Thus, we can postulate that Gα s and its yet to be defined coupled receptors may preserve the integrity and function of the epidermis and its resident self-renewing stem cells, ensuring proper tissue homeostasis and protecting against cancerous growth. We believe that this study will prompt the in-depth analysis of alterations in Gα s and Gα s -coupled receptors, and perhaps Gαi-coupled receptors that counteract Gα s signalling, in future cancer genomic studies, in light of the unique stem cell regulatory and tumour suppressive functions of Gα s and PKA.
METHODS
Methods and any associated references are available in the online version of the paper. 
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METHODS DNA constructs. pCMX-GAL4TEAD and pGL4.23-5×GAL4-binding UAS promoter luciferase have been described previously 55 . Human YAP1 was cloned by PCR from pDsRed Monomer C1-YAP2 (ADDGENE, Plasmid 19057) with a C-terminal FLAG tag into pCEFL (pCEFL FLAG-YAP1). Human GLI1 was cloned by PCR from pBluescript KS GLI K12 (ADDGENE, Plasmid 16419) with a C-terminal HA tag into pCEFL (pCEFL GLI1HA) or with a C-terminal GAL4 DNA-binding domain followed by a HA tag into pCEFL (pCEFL GAL4GLI). The PKA inhibitor (PKI) was cloned by inserting the 24 amino acids after the initial methionine of the coding sequence of human PKI downstream of GFP (GFP-PKI). For use as a control, the phenylalanine and arginine residues of the PKI peptide were replaced with alanine to disrupt binding to PKA, named GFP-PKI4A (see Fig. 4a ). GNASR201C active mutant was generated using the Stratagene site-directed mutagenesis approach and a Gα s long EE tag (internal) from Missouri S&T cDNA Resource Center (Catalogue Number: GNA0SLEI00) as the wild-type template.
Mice. All animal studies were carried out according to NIH-Intramural Animal Care and Use Committee (ACUC)-approved protocols, in compliance with the Guide for the Care and Use of Laboratory Animals. Mice carrying a tamoxifen-inducible Cre-mediated recombination system driven by the human keratin 14 promoter (K14CreER mice) were from The Jackson Laboratory (Stock Number 005107, STOCK Tg(KRT14-cre/ERT)20Efu/JK14Cre). Epithelial-specific Gnas knockouts were obtained by crossing K14CreER mice with mice carrying loxP sites surrounding Gnas exon 1 (refs 9,56) . Gli lz reporter mice were described previously 17 and they were obtained from The Jackson Laboratory (Stock Number: 008211, STOCK Gli1tm2Alj/J). FVB/N mice carrying the cytokeratin 5 promoter in the reverse tetracycline transactivator (rtTA) (K5rtTA) have been previously described 35 . For the generation of Tet-GFP-PKI, Tet-GFP-PKI4A and Tet-Gα s R201C transgenic mice, the GFP-PKI, GFP-PKI4A and Gα s R201C coding sequences were cloned downstream of the seven Tet-responsive element (TetO7) in a modified pBSRV vector 57 . The fragment containing the expression cassette was isolated by PmeI digestion from vector DNA and purified for micro-injection into FVB/N mouse fertilized oocytes. Founders were identified for the presence of the transgene by screening genomic DNA from tail biopsies using a PCR reaction. The presence of wild-type, floxed and recombined Gsα was analysed as previously described 56 . The presence of the GFP-PKI and GFP-PKI4A transgenes was determined with the following primers: forward sequence 5 -CTAGAATTCGCTGTCTGCGA-3 , reverse sequence 5 -CTCGGCATGGACGAGCTGTA-3 , band approximately 1,100 bp. The presence of the Gα s R201C transgene was determined with the following primers: forward sequence 5 -CTAGAATTCGCTGTCTGCGA-3 , reverse sequence 5 -GCACTTTGGTTGCCTTCTC-3 , band approximately 620 bp. PCR reactions were performed with the following cycles: 95 • C for 4 min, followed by 3 cycles of 95 • C for 1 min, 55 • C for 1 min, and 72 • C for 1.5 min, and a final cycle with 10 min of extension at 72 • C. The investigators were not blinded to allocation of samples during experiments and outcome assessment. Both male and female mice were used in the studies. Treatment was started between weeks 6 to 10 after birth. No statistical method was used to predetermine sample size. No randomization was used and all experiments were conducted using littermate controls. Doxycycline was administered in the food grain-based pellets (Bio-Serv) at 6 g kg −1 . Tamoxifen (1 mg per mouse, per day, in corn oil) was applied by gavage to one-month-old mice for 5 consecutive days to induce homozygous deletion.
Cell lines, keratinocyte cell culture and transfections. All cells were cultured at 37 • C in the presence of 5% CO 2 . HEK293, HACAT and NIH3T3 were obtained from ATCC and cells were cultured in DMEM (Invitrogen) containing 10% fetal bovine serum (FBS; Sigma-Aldrich) and antibiotic/antimycotic solution (SigmaAldrich). Cells were transfected with Lipofectamine 3000 (Invitrogen) according to the manufacturer's instructions. Keratinocytes from adult mice were isolated and cultured as previously described 20 , except that defined keratinocyte serumfree medium (KSFM; Invitrogen) supplemented with antibiotics was used as culture medium. To assess colony-forming efficiency, equal number of cells from corresponding mice were plated in triplicate in six-well plates and grown for 10 to 14 days and processed and quantified as previously described 58 . Colonies were pseudo-coloured red. For siRNA experiments, primary cells were transfected with the corresponding siRNAs two days after plating and HACAT cells were transfected one day after plating and in all cases cells were treated/collected 48 h after transfection. siRNAs were: from Dharmacon siGENOME SMARTpool mouse Gli1 siRNA M-047917-01-0005, siGENOME SMARTpool mouse Yap1 siRNA M-046247-01-0005, ON-TARGETplus human NF2 siRNA L-003917-00-0005, ON-TARGETplus human SAV1 siRNA L-013070-01-0005, and nontargeting control siRNA D-001206-13; from IDT DsiRNA Duplexes human MST1 5 -AGUUGUCGCAAUUAAACA-3 5 -AGGUACUUGUUUAAUUGC-3 , human MST2 5 -GCAGGUCAACUUACAGAU-3 5 -CCAUGGUAUCUGUAAGUU-3 ; from SIGMA MISSION siRNA human LATS2 SASI_Hs01_00158803, human LATS1 SASI_Hs01_00046128. siRNA was transfected at a concentration of 8 pmol cm −2 using Lipofectamine RNAiMAX (Invitrogen) according to the manufacturer's instructions. β-Gal staining for cells was performed with the β-Gal Staining Kit (Invitrogen), except that staining was performed over a 48 h period in a wet chamber. β-Gal staining was visualized by confocal imaging 59 . Cyclopamine (InSolution) at a final concentration of 5 µM was added in 0.5% FBS DMEM for 24 h for NIH3T3 cells and in supplement free-KSFM for 48 h for mouse keratinocytes. The smoothened agonist SAG (InSolution) at a final concentration of 100 nM was added to the media for 2 days before processing cells for β-Gal staining. Forskolin (Sigma) was used at 10 µM in combination with IBMX (Sigma) 100 µM in complete media for the indicated times.
Gene expression analysis and quantitative PCR. Total skin and cultured keratinocytes RNA was isolated and processed using RNeasy Plus Mini Kit (Qiagen) according to the manufacturer's instructions. Samples were excluded in cases were mRNA quality or tissue quality after processing was poor (below commonly accepted standards). Gene array analysis was performed with the Agilent Mouse GE 4×44K v2 Microarray Kit as previously described 60 using mRNA isolated from ear skin from four Gnas eKO mice with evident lesions (approximately 4 weeks after tamoxifen treatment) and four littermate controls. Gene Ontology (GO) terms were obtained with GeneSpringV10 by considering genes presenting a fold change greater or smaller than 1.8 or −1.8 respectively and GO terms were filtered for development terms. The functional analysis of transcriptional regulators was generated through the use of IPA (Ingenuity Systems, www.ingenuity.com) using genes presenting a fold change greater than 1.8. The YAP1 transcriptional signature was described previously 55 and unsupervised clustering and expression levels were obtained using GeneSpringV10.
One microgram of cDNA was used as a template for quantitative polymerase chain reaction with reverse transcription (qRT-PCR) analysis using iQ SYBR Green Supermix (Bio-Rad). Samples were analysed using a Bio-Rad iCycler iQ multicolour real-time PCR detection system. Oligonucleotides used for amplification were (gene, forward sequence 5 → 3 , reverse sequence 5 → 3 ): Rn18s 5 -GAAACTGCGAAT GGCTCATTAAA-3 , 5 -CCACAGTTATCCAAGTAGGAGAGGA-3 ; Gli1 5 -T GGACAAGTGCAGGTAAAACC-3 , 5 -AATCCGGTGGAGTCAGACC-3 ; Gli2 5 -GCAGACTGCACCAAGGAGTA-3 , 5 -CGTGGATGTGTTCATTGTTGA-3 ; Tail skin whole mounts and βGal stain. Whole mounts were prepared and stained with antibodies (see Immunofluorescence section below) as previously described 61 . For βGal staining, back and ear skin were shaved in the area of dissection and skin was peeled off while cutting the attached subcutaneous layers. Skin and whole mounts were fixed in 2% paraformaldehyde, 0.2% glutaraldehyde, in PBS for 15 min on ice on each side. Then tissue was washed twice for 20 min each with βGal wash solution (2 mM MgCl 2 , 0.1% Nonidet P40, in PBS). Tissues were stained overnight at room temperature, in the dark, on a rolling platform in βGal stain solution (5 mM βgal stain: 10 mM K 3 Fe(CN) 6 , 10 mM K 4 Fe(CN) 6 ·3H20, 2 mM MgCl 2 , 0.1% Nonidet P40, 0.5 mg ml −1 X-gal in DMF, all diluted in PBS). Afterwards, staining solution was removed and tissues were washed twice for 20 min each in βGal wash solution. Tissues were directly visualized or stored in ethanol 70% and processed for paraffin sectioning and stained with Neutral red or processed by cryosectioning.
Immunoblot analysis. Western blot assays were performed as described previously 58, 62 and repeated at least 3 independent times. Antibodies used were: anti-GAPDH (Cell Signaling; clone no. 14C10; catalogue no. 2118; 1:2,000), anti-α-tubulin (Cell Signaling; clone no. DM1A; catalogue no. 3873; 1:2,000), phospho-PKA substrate (RRXS * /T * ) antibody (Cell Signaling; clone no. 100G7E; catalogue no. 9624; 1:1,000), phospho-(Ser/Thr) PKA substrate antibody (Cell Signaling;
